The U.S. Food and Drug Administration has approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In